Recruiting PHASE4 INTERVENTIONAL 1-arm NCT06377371

Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

A Pilot Study to Evaluate Feasibility of Intraoperative Tracing of Meningioma Using [Cu64]DOTATATE

Sponsor: Curium US LLC

Interventions Brain Imaging with [Cu64]DOTATATE Radio-guided Surgery With Neoprobe Utilization

Updated 7 times since 2024 Last updated: Feb 24, 2026 Started: Sep 11, 2024 Primary completion: Jan 31, 2027 Completion: Jan 31, 2027

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Meningioma, this trial is actively recruiting participants. The trial is conducted by Curium US LLC and has accumulated 7 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Feb 2026 — Present [monthly]

Recruiting PHASE4
Apr 2025 — Feb 2026 [monthly]

Recruiting PHASE4
Nov 2024 — Apr 2025 [monthly]

Recruiting PHASE4

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Nov 2024 [monthly]

Not Yet Recruiting PHASE4
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting PHASE4

▶ Show 2 earlier versions

Jun 2024 — Jul 2024 [monthly]

Not Yet Recruiting PHASE4
May 2024 — Jun 2024 [monthly]

Not Yet Recruiting PHASE4

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Curium US LLC
Weill Medical College of Cornell University

Data source: Weill Medical College of Cornell University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States